Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04763655 · ClinicalTrials.gov registry record · NA
Neural Biomarkers of Electroconvulsive Therapy Response
A NA study of Electroconvulsive Therapy Treated Patients, sponsored by Northwell Health.
- Recruiting
- Registry status
- NA
- Development phase
- 75
- Enrollment target
- 1
- Study location
NCT04763655 is a NA study of Electroconvulsive Therapy Treated Patients that is actively recruiting participants, run by Northwell Health. The registered enrollment target is 75 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04763655, a NA study of Electroconvulsive Therapy Treated Patients, is actively recruiting participants, sponsored by Northwell Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
In the proposed study, the investigators will utilize resting-state functional MRI (fMRI) and structural MRI-based electrical field modeling to study the effect of electroconvulsive therapy on human neural circuitry. Our study will recruit patients who are beginning treatment with bilateral electroconvulsive therapy (N=75). Our design will be longitudinal where patients will be followed up until their 8th week electroconvulsive therapy clinically. The primary measure of interest will be the slope of clinical change estimated with mixed effect modeling (see Approach). Secondary measures will be the cognitive performance change between baseline and the 8th week electroconvulsive therapy time point.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST clinical and neuropsychological testing
Study Locations (1)
New York
- The Zucker Hillside Hospital - Glen Oaks
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2020-04-01 |
| Est. Completion | 2025-07-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04763655
The ClinicalTrials.gov registry entry for NCT04763655 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Electroconvulsive Therapy Treated Patients appearing as the primary indexed condition, and to 1 intervention - of which clinical and neuropsychological testing is the first listed.
NCT04763655 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT04763655 about?
NCT04763655 is a clinical study titled "Neural Biomarkers of Electroconvulsive Therapy Response". In the proposed study, the investigators will utilize resting-state functional MRI (fMRI) and structural MRI-based electrical field modeling to study the effect of electroconvulsive therapy on human neural circuitry. Our study will recruit patients who are beginning treatment with bilateral electroc...
What is the current status of trial NCT04763655?
This trial is currently recruiting. It is a NA study. The enrollment target is 75 participants. The study started on 2020-04-01. Estimated completion is 2025-07-01.
What conditions does trial NCT04763655 study?
This clinical trial studies the following conditions: Electroconvulsive Therapy Treated Patients.
What interventions are being tested in trial NCT04763655?
The interventions under investigation include: clinical and neuropsychological testing (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04763655?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04763655 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.